c.lundgren
TL2 Moderator · Bologna
Contributes reviews on supplier material. Based in Bologna.
Joined 26 July 2025 · last posted 1d
79 posts, newest first. Showing up to 150.
-
Type 1 diabetes: off-label use and the evidence gap Replied, post #3 · Clinical › Special populations · 27 Jul 2026 · 1 like Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #122 · Analytics › Home & field testing · 25 Jul 2026 · 22 likes Coming back to post #120, because the follow-up matters more than the original answer. What you can use home tests for: confirmation that a solution contains peptide…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #109 · Compounds › Semaglutide · 25 Jul 2026 · 2 likes This follows post #106 rather than contradicting it. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not…
-
Insurance and replacement policies, compared Replied, post #116 · Sourcing › Logistics · 25 Jul 2026 · 0 likes Worth separating two things that post #112 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #59 · Pharmacology › Pharmacokinetics · 23 Jul 2026 · 20 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Pooling trials with different estimands Replied, post #120 · Evidence › Meta-analyses · 22 Jul 2026 · 5 likes On post #116 — agreed on the reasoning, with one qualification. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups…
-
An appeal that succeeded, with the letter structure Replied, post #16 · Access › Insurance & coverage · 22 Jul 2026 · 0 likes post #15 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #79 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Picking up post #76: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A single out-of-range value on an otherwise normal panel Replied, post #73 · Clinical › Bloodwork · 15 Jul 2026 · 18 likes Coming back to post #71, because the follow-up matters more than the original answer. Time of day: some biomarkers vary across the day. Cortisol in the morning differs…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #67 · Practice › Administration · 8 Jul 2026 · 1 like Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #46 · Outcomes › Body composition · 6 Jul 2026 · 0 likes post #45 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Pooling trials with different estimands Replied, post #72 · Evidence › Meta-analyses · 5 Jul 2026 · 2 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #10 · Clinical › Bloodwork · 28 Jun 2026 · 4 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #49 · Compounds › Tirzepatide · 20 Jun 2026 · 1 like I read post #47 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #64 · Sourcing › Red flags · 16 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A structured critique template this community uses — a second dataset Replied, post #9 · Evidence › Study critique · 13 Jun 2026 · 15 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #48 · Practice › Dosing & titration · 11 Jun 2026 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
An 18-month record including the parts that went badly Replied, post #38 · Outcomes › Progress reports · 11 Jun 2026 · 2 likes Coming back to post #36, because the follow-up matters more than the original answer. Exercise volume changes: increasing exercise intensity or duration can mask weight…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #32 · Wellbeing › Sleep · 10 Jun 2026 · 12 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #14 · Start Here › How to Ask · 2 Jun 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #52 · Evidence › Journal club · 9 May 2026 · 24 likes Worth separating two things that post #48 runs together. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #7 · Practice › Side effects · 6 May 2026 · 5 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #81 · Clinical › Comorbidities · 24 Apr 2026 · 21 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Spike-and-recover accuracy for a peptide assay Replied, post #74 · Analytics › Method validation · 9 Apr 2026 · 0 likes This follows post #71 rather than contradicting it. Range: the concentration range over which the method has been validated. Going outside the validated range is going…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #47 · Sourcing › Vendor reports · 7 Apr 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #96 · Pharmacology › Pharmacokinetics · 6 Apr 2026 · 2 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Labelling requirements for research chemicals Replied, post #6 · Sourcing › Regulatory · 1 Apr 2026 · 27 likes Picking up post #3: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #59 · Compounds › Tirzepatide · 27 Mar 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #87 · Clinical › Special populations · 26 Mar 2026 · 0 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #39 · Practice › Reconstitution · 11 Mar 2026 · 0 likes Picking up post #36: that is the part I would want checked first. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #15 · Compounds › Repair & healing peptides · 9 Mar 2026 · 13 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Contributing data without breaching anyone's privacy Replied, post #15 · Data & Tools › Datasets · 3 Mar 2026 · 8 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #7 · Clinical › Bloodwork · 2 Mar 2026 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
The lowest dose that does anything: is that a real question? Replied, post #23 · Practice › Dosing & titration · 2 Mar 2026 · 4 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Measurement error in a self-reported exposure Replied, post #44 · Evidence › Study critique · 24 Feb 2026 · 25 likes I read post #42 twice before replying, because I had assumed the opposite. Bias towards the null and bias away from the null: different criticisms have different…
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #5 · Evidence › Journal club · 16 Feb 2026 · 27 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Coming back to: Training through a dose escalation week Replied, post #18 · Nutrition & Training › Resistance training · 30 Jan 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #57 · Clinical › Special populations · 24 Jan 2026 · 1 like Picking up post #54: that is the part I would want checked first. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #22 · Evidence › Trials · 8 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #24 · Compounds › Oral incretins · 31 Oct 2025 · 30 likes Picking up post #21: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Why appetite effects are mostly central Replied, post #80 · Pharmacology › Receptor biology · 28 Oct 2025 · 2 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Temperature loggers worth the money Replied, post #44 · Devices › Cold chain · 20 Oct 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Bleeding at the injection site: normal, and what to do about it Replied, post #2 · Practice › Administration · 11 Oct 2025 · 5 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Column chemistry choices for a 40-residue peptide Replied, post #38 · Analytics › HPLC & UHPLC · 16 Sep 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Request: a diff view for wiki revisions — the long version Replied, post #42 · Meta › Feature requests · 13 Sep 2025 · 20 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Liver enzymes drifting down and what that usually means Replied, post #9 · Clinical › Bloodwork · 5 Sep 2025 · 22 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
When a preprint is the best available evidence and we say so Replied, post #125 · Evidence › Preprints · 1 Sep 2025 · 8 likes Coming back to post #123, because the follow-up matters more than the original answer. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #118 · Compounds › Secretagogues & GH axis · 31 Aug 2025 · 12 likes This follows post #115 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
High-resolution MS on aggregates and what it can see Replied, post #42 · Analytics › Mass spectrometry · 12 Aug 2025 · 30 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Substitution between formats during a shortage Replied, post #36 · Access › Shortages · 9 Aug 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A ten-fold dose error caught before injection — one year on Replied, post #110 · Devices › Syringes & needles · 4 Aug 2025 · 1 like This follows post #107 rather than contradicting it. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant…
-
Interim analyses and stopping rules — does this still hold? Replied, post #34 · Evidence › Trials · 5 Jul 2025 · 0 likes This follows post #31 rather than contradicting it. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
-
Revisiting: German, French and Dutch differences, compared Replied, post #41 · Regional › European Union · 4 Jul 2025 · 30 likes post #40 is right about the mechanism and I think understates the practical bit. Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #48 · Evidence › Trials · 29 Jun 2025 · 11 likes Worth separating two things that post #44 runs together. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
-
Specification in the result column: why that is a meaningful error Replied, post #12 · Analytics › COA interpretation · 25 Jun 2025 · 5 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #10 · Compounds › Semaglutide · 4 Jun 2025 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #36 · Practice › Storage & stability · 7 May 2025 · 0 likes Worth separating two things that post #32 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #57 · Wellbeing › Mental health · 7 May 2025 · 4 likes post #56 is right about the mechanism and I think understates the practical bit. Identity and self-image: for some people, weight and body size are central to identity.…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #7 · Evidence › Journal club · 4 Apr 2025 · 4 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #28 · Safety › Contraindications · 23 Mar 2025 · 7 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
A ten-fold dose error caught before injection Replied, post #11 · Devices › Syringes & needles · 20 Mar 2025 · 21 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Coming back to: How to tell whether your question is already answered on a maintained page Replied, post #3 · Start Here › Welcome · 1 Mar 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Canadian access and provincial variation Replied, post #2 · Regional › North America · 18 Jan 2025 · 19 likes On the opening post — agreed on the reasoning, with one qualification. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #129 · Compounds › Tirzepatide · 4 Jan 2025 · 3 likes This follows post #126 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #3 · Practice › Dosing & titration · 31 Dec 2024 · 15 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Fixed versus detachable needles: the trade-offs Replied, post #75 · Devices › Syringes & needles · 27 Dec 2024 · 12 likes Worth separating two things that post #71 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #60 · Compounds › Semaglutide · 22 Dec 2024 · 1 like The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Washout with a one-week half-life: the arithmetic Replied, post #67 · Research Methods › N-of-1 designs · 4 Dec 2024 · 7 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #122 · Compounds › Repair & healing peptides · 23 Nov 2024 · 5 likes post #121 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #3 · Nutrition & Training › Resistance training · 1 Nov 2024 · 29 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #58 · Wellbeing › Mental health · 29 Oct 2024 · 1 like Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Requesting a page: what makes a good request — what changed since Replied, post #51 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #13 · Compounds › Other compounds · 22 Sep 2024 · 0 likes On post #9 — agreed on the reasoning, with one qualification. This subcategory exists because some people will research compounds outside the main groups discussed…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #66 · Nutrition & Training › Hydration & electrolytes · 30 Aug 2024 · 13 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #19 · Compounds › Oral incretins · 29 Aug 2024 · 31 likes On post #15 — agreed on the reasoning, with one qualification. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations.…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #38 · Analytics › COA interpretation · 11 Aug 2024 · 28 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #32 · Clinical › Prescriber conversations · 5 Aug 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Assessing a warm arrival: the decision process — one year on Replied, post #77 · Sourcing › Logistics · 31 May 2024 · 32 likes post #76 is right about the mechanism and I think understates the practical bit. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there…
-
Assessing a warm arrival: the decision process — one year on Replied, post #5 · Sourcing › Logistics · 28 May 2024 · 16 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…